Share Prices & Company Research

Stockbroking

4d Pharma Ord 0.25p

Current Price 231.00p Bid 231.00p Ask 240.00p Change 16.15%
Last Updated: 22/06/2018 19:55. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

4d pharma plc is a pharmaceutical company focusing on significant new therapeutic areas. The company will develop pharmaceutical assets utilising managements' expertise. Each member of the Board have a global network of contacts in this sector and track record to attract assets. The Board will develop a number of projects by targeting platform technologies in new therapeutic areas that demonstrate defined patient populations with unmet needs and a clear, rapid regulatory pathway. The first project is the microbiome, and the company intends to build a program of therapeutics in this field with the first development targeting auto-immune diseases.

Financial Highlights Year Ended 31/12/2017

Turnover
£0.00m
Operating Profit
£-24.35m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-6.46

Key Personnel

Duncan Joseph Peyton
Chief Executive Officer
Alexander James Stevenson
Chief Scientific Officer
David Robert Norwood
Non-Executive Chairman
Thomas Engelen
Non-Executive Director

Stock Details

EPIC
DDDD
ISIN
GB00BJL5BR07
Shares in Issue
65,493,842
Market cap
£132.79m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
235.50p
Bid Price
231.00p
Ask Price
240.00p
Volume
78649
Change Today
32.75p
% Change Today
16.15%
Open
188.00p
Previous Close
235.50p
Intraday High
250.00p
Intraday Low
188.00p
52 Week High
467.00p
52 Week Low
114.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

4d Pharma  Ord 0.25p Intra-day Chart

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
5.2
3.9
Intangible Assets & Goodwill
14.7
14.3
Investments & Other Non-Current Assets
0.1
0.0
Total Non-Current Assets
19.9
18.2
Inventory
0.3
0.2
Trade & Receivables
3.2
2.7
Cash & Receivables
11.9
28.7
Other Current Assets & Assets Held for Resale
42.4
43.4
Total Assets
77.7
93.2

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
5.0
4.9
Long Term Liabilities
3.0
1.7
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
8.0
6.7

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
69.8
86.5

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
0.2
0.2
Minority Interests
0.0
0.0
Retained Earnings
-39.9
-19.4
Share Premium Account
108.3
105.9
Other Equity
1.2
-0.2
Total Equity
69.8
86.5

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
-17.2
-13.5
Cashflow Before Financing
-16.8
26.5
Increase / Decrease in Cash
-16.8
26.9

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
0.0
0.0
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-24.4
-12.3
Pre-Tax Profit
-24.0
-11.7
Profit / Loss for the Year
-20.5
-9.9
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.